Treatment of Nightmares in PTSD and Nightmare Disorder

Guideline-Based Treatment Hierarchy

The American Academy of Sleep Medicine recommends Image Rehearsal Therapy (IRT) as the first-line non-pharmacological intervention for nightmare disorder, involving rewriting nightmare content into positive scenarios and rehearsing for 10-20 minutes daily 1
The American Academy of Sleep Medicine recommends prazosin as the most established medication for nightmare disorder, starting at 1 mg at bedtime and titrating by 1-2 mg every few days to effective doses of 3-4 mg/day for civilians or 9.5-15.6 mg/day for veterans 1
The American Academy of Sleep Medicine recommends clonidine 0.1 mg twice daily, titrating to 0.2 mg/day average dose, as a second-line pharmacological option for nightmare disorder 2
The American Academy of Sleep Medicine recommends risperidone 0.5-2.0 mg at bedtime, with 80% of patients reporting improvement after the first dose, as a second-line pharmacological option for nightmare disorder 2
The American Academy of Sleep Medicine recommends aripiprazole 15-30 mg/day as a third-line option for nightmare disorder, with better tolerability than olanzapine 2

The American Academy of Sleep Medicine recommends initiating Image Rehearsal Therapy as first-line non-pharmacological treatment for nightmare disorder 1
The American Academy of Sleep Medicine recommends adding prazosin starting at 1 mg at bedtime, monitoring blood pressure after initial dose and with each significant increase, if Image Rehearsal Therapy is ineffective 1
The American Academy of Sleep Medicine recommends switching to clonidine 0.1 mg twice daily if prazosin is ineffective or not tolerated 2
The American Academy of Sleep Medicine recommends considering risperidone 0.5-2.0 mg at bedtime if clonidine fails 2
The American Academy of Sleep Medicine recommends trying aripiprazole 15-30 mg/day if risperidone is ineffective or not tolerated 2

The American Academy of Sleep Medicine specifically recommends against using clonazepam or venlafaxine for nightmare disorder 2
The American Academy of Sleep Medicine recommends monitoring blood pressure carefully with prazosin, clonidine, and trazodone due to orthostatic hypotension risk 2, 1
The American Academy of Sleep Medicine recommends avoiding nefazodone as first-line therapy due to hepatotoxicity concerns 2
The American Academy of Sleep Medicine notes that symptoms typically return to baseline intensity if medications are discontinued, with return of nightmares expected 2, 1

The American Academy of Sleep Medicine identifies prazosin as the most established medication for nightmare disorder, with doses ranging from 1-16mg/day showing efficacy 3
Evidence supports clonidine doses of 0.2-0.6mg/day in divided doses, with most patients responding to 0.2mg/day average 4
The American Academy of Sleep Medicine supports olanzapine for PTSD-associated nightmares, with case series showing rapid improvement at 10-20mg/day 5, 6
Olanzapine 15mg is an appropriate and evidence-based dose for nightmare treatment, but monitor for metabolic side effects 5
Buspirone has no established role in nightmare treatment and is not mentioned in any American Academy of Sleep Medicine guidelines for nightmare disorder 3, 6, 7

Image Rehearsal Therapy is the only "recommended" treatment by the American Academy of Sleep Medicine, involving rewriting nightmare content into positive scenarios and rehearsing 10-20 minutes daily while awake 3, 6, 7
Three sessions of Image Rehearsal Therapy (two 3-hour sessions one week apart, with 1-hour follow-up 3 weeks later) show significant efficacy 6, 7

The combination of olanzapine 15mg + mirtazapine 45mg creates substantial sedation and metabolic risk 5
Two alpha-adrenergic agents (prazosin + clonidine) is redundant and increases hypotension risk 4

Risperidone 0.5-2.0mg at bedtime has an 80% response rate after first dose and may be considered if nightmares persist after prazosin optimization 4
Aripiprazole 15-30mg/day may be considered as an alternative to olanzapine, with better tolerability 4, 5

The American Academy of Sleep Medicine specifically recommends against using clonazepam or venlafaxine for nightmare disorder 3, 6, 7

Prazosin can paradoxically intensify dream vividness in a subset of patients, with this adverse effect reported early in treatment at doses as low as 1 mg. (American Academy of Sleep Medicine, observational data) [8][9]
The American Academy of Sleep Medicine guidelines note that initiation of prazosin at standard starting doses may worsen dream vividness in some individuals. (Guideline, Level B) 8

Clonidine should not be used as an alternative to prazosin for nightmare management because it shares the same alpha‑adrenergic mechanism and may similarly intensify dreams. (American Academy of Sleep Medicine, expert opinion) 8

Image Rehearsal Therapy (IRT) is recommended as the primary treatment for PTSD‑related nightmares; it involves rewriting nightmare content into positive scenarios and rehearsing them for 10–20 minutes daily while awake. (American Academy of Sleep Medicine, Level A) 8
IRT is the only “recommended” (Level A) intervention for nightmare disorder according to the American Academy of Sleep Medicine, offering efficacy without medication‑related side effects. (Guideline, Level A) 8

Risperidone 0.5–1.0 mg taken at bedtime may be considered after 4–6 weeks of unsuccessful IRT; studies report an approximate 80 % response rate after the first dose and no reported dream intensification. (Observational cohort, moderate evidence) [8][9]
Low‑dose aripiprazole (5–10 mg daily) may provide benefit for PTSD‑associated nightmares through dopaminergic modulation, although supporting data are limited to case series. (Case series, low‑level evidence) 9
Trazodone should be avoided for nightmare treatment because it is associated with significant daytime sedation and orthostatic hypotension in about 60 % of patients. (Observational data, moderate evidence) 9